GM vs XERS · P/E 7.5, rev $91.65B vs rev $175.2M
General Motors Company (GM) versus Xeris Pharmaceuticals Inc (XERS) — a side-by-side from cached financials, not a winner call.
General Motors Company (GM) is a auto manufacturers company listed on US. It is led by Mary T. Barra.
Xeris Pharmaceuticals Inc (XERS) is a biotechnology company listed on US.
Latest reported GM revenue for 2026-06-30 was $91.65B. Net income was $3.93B. GM currently screens at market cap $51.33B and trailing P/E 7.5.
Latest reported XERS revenue for 2026-06-30 was $175.2M. Net income was -$28.9M. XERS currently screens at market cap $760.7M.
GM currently screens at market cap $51.33B and trailing P/E 7.5. XERS currently screens at market cap $760.7M.
Not investment advice. Open the GM and XERS stock pages for the full models.
Not investment advice.